公开(公告)号：WO1998018467A1

公开(公告)日：1998-05-07

申请号：PCT/US1997018722

申请日：1997-10-21

Applicant: BAXTER INTERNATIONAL INC.

Inventor： BAXTER INTERNATIONAL INC. ,  BERGSTRÖM, Jonas

IPC: A61K31/415

CPC classification number: A61K31/4172 ,  A61K33/14 ,  A61K2300/00

Abstract: Methods and compositions for treating renal failure patients are provided. Pursuant to the present invention, a renal failure patient is provided with an intravenous or dialysis solution that includes a therapeutically effective amount of L-carnosine. In part, the L-carnosine will prevent the renal failure patient from developing L-carnosine deficiency.

Abstract translation: 提供了治疗肾衰竭患者的方法和组合物。 根据本发明，向肾衰竭患者提供包含治疗有效量的L-肌肽的静脉内或透析溶液。 部分地，L-肌肽会阻止肾衰竭患者发生L-肌肽缺乏症。

公开(公告)号：EP0869788B1

公开(公告)日：2006-01-25

申请号：EP97911001.2

申请日：1997-10-21

Applicant: Baxter International Inc.

Inventor： BERGSTRÖM, Jonas

IPC: A61K31/415 ,  A61K38/05 ,  A61P7/08 ,  A61P13/12

CPC classification number: A61K31/4172 ,  A61K33/14 ,  A61K2300/00

Abstract: Methods and compositions for treating renal failure patients are provided. Pursuant to the present invention, a renal failure patient is provided with an intravenous or dialysis solution that includes a therapeutically effective amount of L-carnosine. In part, the L-carnosine will prevent the renal failure patient from developing L-carnosine deficiency.

公开(公告)号：EP0869788A1

公开(公告)日：1998-10-14

申请号：EP97911001.0

申请日：1997-10-21

Applicant: BAXTER INTERNATIONAL INC.

Inventor： BERGSTRÖM, Jonas

IPC: A61K38 ,  A61K31 ,  A61K33 ,  A61P13

CPC classification number: A61K31/4172 ,  A61K33/14 ,  A61K2300/00

Abstract: Methods and compositions for treating renal failure patients are provided. Pursuant to the present invention, a renal failure patient is provided with an intravenous or dialysis solution that includes a therapeutically effective amount of L-carnosine. In part, the L-carnosine will prevent the renal failure patient from developing L-carnosine deficiency.